CRISPR-Cas9/Cas12a biotechnology and application in bacteria

Synthetic and Systems Biotechnology

Volumn 3, Issue 3, 2018, Pages 135-149

  Yao, Ruilian ^a   Liu, Di ^b   Jia, Xiao ^a   Zheng, Yuan ^a   Liu, Wei ^a   Xiao, Yi ^a  

^a Shanghai Jiao Tong University   (China)

^b SANDIA NATIONAL LABORATORIES   (United States)

Author keywords

Base editing; Cas12a (Cpf1); Cas13; Cas9; DNA RNA detection

Indexed keywords

TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; ZINC FINGER NUCLEASE;

BACILLUS; BIOGENESIS; BIOTECHNOLOGY; CLOSTRIDIUM; CORYNEBACTERIUM; CRISPR CAS SYSTEM; CRISPR CAS12A SYSTEM; CYANOBACTERIUM; GENE CONTROL; GENE EXPRESSION; LACTIC ACID BACTERIUM; METABOLIC ENGINEERING; NONHUMAN; NUCLEIC ACID ANALYSIS; REGULATORY MECHANISM; REVIEW; RNA CLEAVAGE; RNA EDITING; STREPTOMYCES; TYPE II SECRETION SYSTEM; TYPE V SECRETION SYSTEM;

EID: 85054124456     PISSN: None     EISSN: 2405805X     Source Type: Journal    
DOI: 10.1016/j.synbio.2018.09.004     Document Type: Review

References (259)

1. Hille, F., Richter, H., Wong, S.P., Bratovic, M., Ressel, S., Charpentier, E., The biology of CRISPR-Cas: backward and forward. Cell 172 (2018), 1239–1259.
2. Koonin, E.V., Makarova, K.S., Zhang, F., Diversity, classification and evolution of CRISPR-Cas systems. Curr Opin Microbiol 37 (2017), 67–78.
3. Mitsunobu, H., Teramoto, J., Nishida, K., Kondo, A., Beyond native Cas9: manipulating genomic information and function. Trends Biotechnol 35 (2017), 983–996.
4. Bowater, R., Doherty, A.J., Making ends meet: repairing breaks in bacterial DNA by non-homologous end-joining. PLoS Genet, 2, 2006, e8.
5. Tian, P., Wang, J., Shen, X., Rey, J.F., Yuan, Q., Yan, Y., Fundamental CRISPR-Cas9 tools and current applications in microbial systems. Synth Syst Biotechnol 2 (2017), 219–225.
6. Selle, K., Barrangou, R., Harnessing CRISPR-Cas systems for bacterial genome editing. Trends Microbiol 23 (2015), 225–232.
7. David, F., Siewers, V., Advances in yeast genome engineering. FEMS Yeast Res 15 (2015), 1–14.
8. Esvelt, K.M., Wang, H.H., Genome-scale engineering for systems and synthetic biology. Mol Syst Biol, 9, 2013, 641.
9. Chen, J.S., Ma, E., Harrington, L.B., Da Costa, M., Tian, X., Palefsky, J.M., Doudna, J.A., CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science 360 (2018), 436–439.
10. Gootenberg, J.S., Abudayyeh, O.O., Kellner, M.J., Joung, J., Collins, J.J., Zhang, F., Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science 360 (2018), 439–444.
11. Li, S.Y., Cheng, Q.X., Liu, J.K., Nie, X.Q., Zhao, G.P., Wang, J., CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA. Cell Res 28 (2018), 491–493.
12. Lian, J., HamediRad, M., Zhao, H., Advancing Metabolic Engineering of Saccharomyces cerevisiae Using the CRISPR/Cas System. Biotechnol J, 2018, e1700601.
13. Adli, M., The CRISPR tool kit for genome editing and beyond. Nat Commun, 9, 2018, 1911.
14. Deng, H., Gao, R., Liao, X., Cai, Y., CRISPR system in filamentous fungi: current achievements and future directions. Gene 627 (2017), 212–221.
15. Soda, N., Verma, L., Giri, J., CRISPR-Cas9 based plant genome editing: significance, opportunities and recent advances. Plant Physiol Biochem 131 (2018), 2–11.
16. Swarts, D.C., Jinek, M., Cas9 versus Cas12a/Cpf1: structure-function comparisons and implications for genome editing. 2018, Wiley Interdiscip Rev RNA, e1481.
17. Jackson, S.A., McKenzie, R.E., Fagerlund, R.D., Kieper, S.N., Fineran, P.C., Brouns, S.J., CRISPR-Cas: adapting to change. Science, 356, 2017.
18. Heler, R., Samai, P., Modell, J.W., Weiner, C., Goldberg, G.W., Bikard, D., Marraffini, L.A., Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature 519 (2015), 199–202.
19. Wei, Y., Terns, R.M., Terns, M.P., Cas9 function and host genome sampling in Type II-A CRISPR-Cas adaptation. Genes Dev 29 (2015), 356–361.
20. Stella, S., Alcon, P., Montoya, G., Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage. Nature 546 (2017), 559–563.
21. Deveau, H., Barrangou, R., Garneau, J.E., Labonte, J., Fremaux, C., Boyaval, P., Romero, D.A., Horvath, P., Moineau, S., Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 190 (2008), 1390–1400.
22. Mojica, F.J., Diez-Villasenor, C., Garcia-Martinez, J., Almendros, C., Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155 (2009), 733–740.
23. Swarts, D.C., Mosterd, C., van Passel, M.W., Brouns, S.J., CRISPR interference directs strand specific spacer acquisition. PloS One, 7, 2012, e35888.
24. Fonfara, I., Richter, H., Bratovic, M., Le Rhun, A., Charpentier, E., The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532 (2016), 517–521.
25. Zetsche, B., Gootenberg, J.S., Abudayyeh, O.O., Slaymaker, I.M., Makarova, K.S., Essletzbichler, P., Volz, S.E., Joung, J., van der Oost, J., Regev, A., et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163 (2015), 759–771.
26. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D.A., Horvath, P., CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.
27. Anders, C., Niewoehner, O., Duerst, A., Jinek, M., Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513 (2014), 569–573.
28. Jiang, F., Zhou, K., Ma, L., Gressel, S., Doudna, J.A., STRUCTURAL BIOLOGY. A Cas9-guide RNA complex preorganized for target DNA recognition. Science 348 (2015), 1477–1481.
29. Brouns, S.J., Jore, M.M., Lundgren, M., Westra, E.R., Slijkhuis, R.J., Snijders, A.P., Dickman, M.J., Makarova, K.S., Koonin, E.V., van der Oost, J., Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321 (2008), 960–964.
30. Haurwitz, R.E., Jinek, M., Wiedenheft, B., Zhou, K., Doudna, J.A., Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 329 (2010), 1355–1358.
31. Deltcheva, E., Chylinski, K., Sharma, C.M., Gonzales, K., Chao, Y., Pirzada, Z.A., Eckert, M.R., Vogel, J., Charpentier, E., CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471 (2011), 602–607.
32. Gasiunas, G., Barrangou, R., Horvath, P., Siksnys, V., Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A 109 (2012), E2579–E2586.
33. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–821.
34. Jinek, M., Jiang, F., Taylor, D.W., Sternberg, S.H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science, 343, 2014, 1247997.
35. Nishimasu, H., Ran, F.A., Hsu, P.D., Konermann, S., Shehata, S.I., Dohmae, N., Ishitani, R., Zhang, F., Nureki, O., Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156 (2014), 935–949.
36. Yamano, T., Nishimasu, H., Zetsche, B., Hirano, H., Slaymaker, I.M., Li, Y., Fedorova, I., Nakane, T., Makarova, K.S., Koonin, E.V., et al. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165 (2016), 949–962.
37. Gao, P., Yang, H., Rajashankar, K.R., Huang, Z., Patel, D.J., Type V CRISPR-Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition. Cell Res 26 (2016), 901–913.
38. Sternberg, S.H., LaFrance, B., Kaplan, M., Doudna, J.A., Conformational control of DNA target cleavage by CRISPR-Cas9. Nature 527 (2015), 110–113.
39. Szczelkun, M.D., Tikhomirova, M.S., Sinkunas, T., Gasiunas, G., Karvelis, T., Pschera, P., Siksnys, V., Seidel, R., Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes. Proc Natl Acad Sci U S A 111 (2014), 9798–9803.
40. Jiang, F., Taylor, D.W., Chen, J.S., Kornfeld, J.E., Zhou, K., Thompson, A.J., Nogales, E., Doudna, J.A., Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage. Science 351 (2016), 867–871.
41. Swarts, D.C., van der Oost, J., Jinek, M., Structural basis for guide RNA processing and seed-dependent DNA targeting by CRISPR-Cas12a. Mol Cell 66 (2017), 221–233 e4.
42. Stella, S., Alcon, P., Montoya, G., Class 2 CRISPR-Cas RNA-guided endonucleases: swiss Army knives of genome editing. Nat Struct Mol Biol 24 (2017), 882–892.
43. Borges, A.L., Davidson, A.R., Bondy-Denomy, J., The discovery, mechanisms, and evolutionary impact of anti-CRISPRs. Annu Rev Virol 4 (2017), 37–59.
44. Maxwell, K.L., The anti-CRISPR story: a battle for survival. Mol Cell 68 (2017), 8–14.
45. Pawluk, A., Davidson, A.R., Maxwell, K.L., Anti-CRISPR: discovery, mechanism and function. Nat Rev Microbiol 16 (2018), 12–17.
46. Bondy-Denomy, J., Pawluk, A., Maxwell, K.L., Davidson, A.R., Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493 (2013), 429–432.
47. Pawluk, A., Bondy-Denomy, J., Cheung, V.H., Maxwell, K.L., Davidson, A.R., A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa. mBio, 5, 2014, e00896.
48. Pawluk, A., Staals, R.H., Taylor, C., Watson, B.N., Saha, S., Fineran, P.C., Maxwell, K.L., Davidson, A.R., Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nat Microbiol, 1, 2016, 16085.
49. Rauch, B.J., Silvis, M.R., Hultquist, J.F., Waters, C.S., McGregor, M.J., Krogan, N.J., Bondy-Denomy, J., Inhibition of CRISPR-Cas9 with bacteriophage proteins. Cell 168 (2017), 150–158.
50. Bondy-Denomy, J., Garcia, B., Strum, S., Du, M., Rollins, M.F., Hidalgo-Reyes, Y., Wiedenheft, B., Maxwell, K.L., Davidson, A.R., Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins. Nature 526 (2015), 136–139.
51. Chowdhury, S., Carter, J., Rollins, M.F., Golden, S.M., Jackson, R.N., Hoffmann, C., Nosaka, L., Bondy-Denomy, J., Maxwell, K.L., Davidson, A.R., et al. Structure reveals mechanisms of viral suppressors that intercept a CRISPR RNA-guided surveillance complex. Cell 169 (2017), 47–57.
52. Dong, D., Guo, M., Wang, S., Zhu, Y., Wang, S., Xiong, Z., Yang, J., Xu, Z., Huang, Z., Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein. Nature 546 (2017), 436–439.
53. Maxwell, K.L., Garcia, B., Bondy-Denomy, J., Bona, D., Hidalgo-Reyes, Y., Davidson, A.R., The solution structure of an anti-CRISPR protein. Nat Commun, 7, 2016, 13134.
54. Wang, X., Yao, D., Xu, J.G., Li, A.R., Xu, J., Fu, P., Zhou, Y., Zhu, Y., Structural basis of Cas3 inhibition by the bacteriophage protein AcrF3. Nat Struct Mol Biol 23 (2016), 868–870.
55. Wang, J., Ma, J., Cheng, Z., Meng, X., You, L., Wang, M., Zhang, X., Wang, Y., A CRISPR evolutionary arms race: structural insights into viral anti-CRISPR/Cas responses. Cell Res 26 (2016), 1165–1168.
56. Harrington, L.B., Doxzen, K.W., Ma, E., Liu, J.J., Knott, G.J., Edraki, A., Garcia, B., Amrani, N., Chen, J.S., Cofsky, J.C., et al. A broad-spectrum inhibitor of CRISPR-Cas9. Cell 170 (2017), 1224–1233.
57. Yang, H., Patel, D.J., Inhibition mechanism of an anti-CRISPR suppressor AcrIIA4 targeting SpyCas9. Mol Cell 67 (2017), 117–127.
58. Shin, J., Jiang, F., Liu, J.J., Bray, N.L., Rauch, B.J., Baik, S.H., Nogales, E., Bondy-Denomy, J., Corn, J.E., Doudna, J.A., Disabling Cas9 by an anti-CRISPR DNA mimic. Sci Adv, 3, 2017, e1701620.
59. Dong, Guo M., Wang, S., Zhu, Y., Wang, S., Xiong, Z., Yang, J., Xu, Z., Huang, Z., Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein. Nature 546 (2017), 436–439.
60. Pawluk, A., Amrani, N., Zhang, Y., Garcia, B., Hidalgo-Reyes, Y., Lee, J., Edraki, A., Shah, M., Sontheimer, E.J., Maxwell, K.L., et al. Naturally occurring off-switches for CRISPR-Cas9. Cell 167 (2016), 1829–18238 e9.
61. Zhang, X., Wang, J., Cheng, Q., Zheng, X., Zhao, G., Wang, J., Multiplex gene regulation by CRISPR-ddCpf1. Cell Discov, 3, 2017, 17018.
62. Dominguez, A.A., Lim, W.A., Qi, L.S., Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation. Nat Rev Mol Cell Biol 17 (2016), 5–15.
63. Hu, J.H., Miller, S.M., Geurts, M.H., Tang, W., Chen, L., Sun, N., Zeina, C.M., Gao, X., Rees, H.A., Lin, Z., et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556 (2018), 57–63.
64. Kleinstiver, B.P., Prew, M.S., Tsai, S.Q., Nguyen, N.T., Topkar, V.V., Zheng, Z., Joung, J.K., Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol 33 (2015), 1293–1298.
65. Kleinstiver, B.P., Prew, M.S., Tsai, S.Q., Topkar, V.V., Nguyen, N.T., Zheng, Z., Gonzales, A.P., Li, Z., Peterson, R.T., Yeh, J.R., et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523 (2015), 481–485.
66. Barrangou, R., Doudna, J.A., Applications of CRISPR technologies in research and beyond. Nat Biotechnol 34 (2016), 933–941.
67. Badran, A.H., Liu, D.R., Development of potent in vivo mutagenesis plasmids with broad mutational spectra. Nat Commun, 6, 2015, 8425.
68. Hubbard, B.P., Badran, A.H., Zuris, J.A., Guilinger, J.P., Davis, K.M., Chen, L., Tsai, S.Q., Sander, J.D., Joung, J.K., Liu, D.R., Continuous directed evolution of DNA-binding proteins to improve TALEN specificity. Nat Methods 12 (2015), 939–942.
69. Badran, A.H., Guzov, V.M., Huai, Q., Kemp, M.M., Vishwanath, P., Kain, W., Nance, A.M., Evdokimov, A., Moshiri, F., Turner, K.H., et al. Continuous evolution of Bacillus thuringiensis toxins overcomes insect resistance. Nature 533 (2016), 58–63.
70. Nishimasu, H., Shi, X., Ishiguro, S., Gao, L., Hirano, S., Okazaki, S., Noda, T., Abudayyeh, O.O., Gootenberg, J.S., Mori, H., et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361 (2018), 1259–1262.
71. Abudayyeh, O.O., Gootenberg, J.S., Essletzbichler, P., Han, S., Joung, J., Belanto, J.J., Verdine, V., Cox, D.B.T., Kellner, M.J., Regev, A., et al. RNA targeting with CRISPR-Cas13. Nature 550 (2017), 280–284.
72. Abudayyeh, O.O., Gootenberg, J.S., Konermann, S., Joung, J., Slaymaker, I.M., Cox, D.B., Shmakov, S., Makarova, K.S., Semenova, E., Minakhin, L., et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 353, 2016 aaf5573.
73. Liu, L., Li, X., Wang, J., Wang, M., Chen, P., Yin, M., Li, J., Sheng, G., Wang, Y., Two distant catalytic sites are responsible for C2c2 RNase activities. Cell, 168, 2017 121-34 e12.
74. Cox, D.B.T., Gootenberg, J.S., Abudayyeh, O.O., Franklin, B., Kellner, M.J., Joung, J., Zhang, F., RNA editing with CRISPR-Cas13. Science 358 (2017), 1019–1027.
75. Cho, S., Shin, J., Cho, B.K., Applications of CRISPR/Cas system to bacterial metabolic engineering. Int J Mol Sci, 19, 2018.
76. Donohoue, P.D., Barrangou, R., May, A.P., Advances in industrial biotechnology using CRISPR-Cas systems. Trends Biotechnol 36 (2018), 134–146.
77. Choi, K.R., Lee, S.Y., CRISPR technologies for bacterial systems: current achievements and future directions. Biotechnol Adv 34 (2016), 1180–1209.
78. Lei, C., Li, S.Y., Liu, J.K., Zheng, X., Zhao, G.P., Wang, J., The CCTL (Cpf1-assisted Cutting and Taq DNA ligase-assisted Ligation) method for efficient editing of large DNA constructs in vitro. Nucleic Acids Res, 45, 2017, e74.
79. Li, S.Y., Zhao, G.P., Wang, J., C-Brick, A new standard for assembly of biological parts using Cpf1. ACS Synth Biol 5 (2016), 1383–1388.
80. Li, S.Y., Zhao, G.P., Wang, J., Protocols for C-brick DNA standard assembly using Cpf1. J Vis Exp, 15, 2017, 124.
81. Jiang, W., Zhao, X., Gabrieli, T., Lou, C., Ebenstein, Y., Zhu, T.F., Cas9-Assisted Targeting of CHromosome segments CATCH enables one-step targeted cloning of large gene clusters. Nat Commun, 6, 2015, 8101.
82. Gaj, T., Gersbach, C.A., Barbas, C.F. 3rd, ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31 (2013), 397–405.
83. Shuman, S., Glickman, M.S., Bacterial DNA repair by non-homologous end joining. Nat Rev Microbiol 5 (2007), 852–861.
84. Jiang, W., Bikard, D., Cox, D., Zhang, F., Marraffini, L.A., RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31 (2013), 233–239.
85. Oh, J.H., van Pijkeren, J.P., CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res, 42, 2014, e131.
86. Liu, D., Xiao, Y., Evans, B., Zhang, F., Negative feedback regulation of fatty acid production based on a malonyl-CoA sensor-actuator. ACS Synth Biol 4 (2014), 132–140.
87. Xiao, Y., Bowen, C.H., Liu, D., Zhang, F., Exploiting nongenetic cell-to-cell variation for enhanced biosynthesis. Nat Chem Biol 12 (2016), 339–344.
88. Qi, L.S., Larson, M.H., Gilbert, L.A., Doudna, J.A., Weissman, J.S., Arkin, A.P., Lim, W.A., Resource repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152 (2013), 1173–1183.
89. Gilbert, L.A., Larson, M.H., Morsut, L., Liu, Z., Brar, G.A., Torres, S.E., Stern-Ginossar, N., Brandman, O., Whitehead, E.H., Doudna, J.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154 (2013), 442–451.
90. Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., Marraffini, L.A., Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res 41 (2013), 7429–7437.
91. Peng, R., Wang, Y., Feng, W.W., Yue, X.J., Chen, J.H., Hu, X.Z., Li, Z.F., Sheng, D.H., Zhang, Y.M., Li, Y.Z., CRISPR/dCas9-mediated transcriptional improvement of the biosynthetic gene cluster for the epothilone production in Myxococcus xanthus. Microb Cell Fact, 17, 2018, 15.
92. Dong, C., Fontana, J., Patel, A., Carothers, J.M., Zalatan, J.G., Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria. Nat Commun, 9, 2018, 2489.
93. Mendoza, B.J., Trinh, C.T., Enhanced guide-RNA design and targeting analysis for precise CRISPR genome editing of single and consortia of industrially relevant and non-model organisms. Bioinformatics 34 (2018), 16–23.
94. Haapaniemi, E., Botla, S., Persson, J., Schmierer, B., Taipale, J., CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med 24 (2018), 927–930.
95. Cox, D.B., Platt, R.J., Zhang, F., Therapeutic genome editing: prospects and challenges. Nat Med 21 (2015), 121–131.
96. Gaudelli, N.M., Komor, A.C., Rees, H.A., Packer, M.S., Badran, A.H., Bryson, D.I., Liu, D.R., Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551 (2017), 464–471.
97. Komor, A.C., Kim, Y.B., Packer, M.S., Zuris, J.A., Liu, D.R., Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533 (2016), 420–424.
98. Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K.Y., et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science, 353, 2016.
99. Li, X., Wang, Y., Liu, Y., Yang, B., Wang, X., Wei, J., Lu, Z., Zhang, Y., Wu, J., Huang, X., et al. Base editing with a Cpf1-cytidine deaminase fusion. Nat Biotechnol 36 (2018), 324–327.
100. Liu, Z., Lu, Z., Yang, G., Huang, S., Li, G., Feng, S., Liu, Y., Li, J., Yu, W., Zhang, Y., et al. Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing. Nat Commun, 9, 2018, 2338.
101. Shimatani, Z., Kashojiya, S., Takayama, M., Terada, R., Arazoe, T., Ishii, H., Teramura, H., Yamamoto, T., Komatsu, H., Miura, K., et al. Targeted base editing in rice and tomato using a CRISPR-Cas9 cytidine deaminase fusion. Nat Biotechnol 35 (2017), 441–443.
102. Eid, A., Alshareef, S., Mahfouz, M.M., CRISPR base editors: genome editing without double-stranded breaks. Biochem J 475 (2018), 1955–1964.
103. Gootenberg, J.S., Abudayyeh, O.O., Lee, J.W., Essletzbichler, P., Dy, A.J., Joung, J., Verdine, V., Donghia, N., Daringer, N.M., Freije, C.A., et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science 356 (2017), 438–442.
104. Compton, J., Nucleic acid sequence-based amplification. Nature 350 (1991), 91–92.
105. Piepenburg, O., Williams, C.H., Stemple, D.L., Armes, N.A., DNA detection using recombination proteins. PLoS Biol, 4, 2006, e204.
106. Keasling, J.D., Manufacturing molecules through metabolic engineering. Science 330 (2010), 1355–1358.
107. Ma, Q., Zhang, Q., Xu, Q., Zhang, C., Li, Y., Fan, X., Xie, X., Chen, N., Systems metabolic engineering strategies for the production of amino acids. Synth Syst Biotechnol 2 (2017), 87–96.
108. Pontrelli, S., Chiu, T.Y., Lan, E.I., Chen, F.Y., Chang, P., Liao, J.C., Escherichia coli as a host for metabolic engineering. Metab Eng, 2018 pii: S1096-7176(18)30074-0.
109. Wang, H.H., Isaacs, F.J., Carr, P.A., Sun, Z.Z., Xu, G., Forest, C.R., Church, G.M., Programming cells by multiplex genome engineering and accelerated evolution. Nature 460 (2009), 894–898.
110. Isaacs, F.J., Carr, P.A., HH W, MJ L, B S, L K, AC T, TA G, DB G, NB R, et al. Precise manipulation of chromosomes in vivo enables genome-wide codon replacement. Science 333 (2011), 348–353.
111. Brophy, J.A.N., Voigt, C.A., Antisense transcription as a tool to tune gene expression. Mol Syst Biol 12 (2016), 854–868.
112. Hsia, J., Holtz, W.J., Maharbiz, M.M., Arcak, M., Keasling, J.D., Modular Synthetic Inverters from Zinc Finger Proteins and Small RNAs. PloS One, 11, 2016, e0149483.
113. Connor, AH-o, Moon, T.S., Development of design rules for reliable antisense RNA behavior in E. coli. ACS Synth Biol 5 (2016), 1441–1454.
114. Jiang, Y., Chen, B., Duan, C., Sun, B., Yang, J., Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system., 81, 2015, 2506–2514.
115. Li, Y., Lin, Z., Huang, C., Zhang, Y., Wang, Z., Metabolic engineering of Escherichia coli using CRISPR – Cas9 meditated genome editing. Metab Eng 31 (2015), 13–21.
116. Liang, L., Liu, R., Garst, A.D., Lee, T., Sànchez, V., Beckham, T., Gill, R.T., CRISPR enabled trackable genome engineering for isopropanol production in Escherichia coli. Metab Eng 41 (2017), 1–10.
117. Keun, S., Hwan, G., Seong, W., Kim, H., Kim, S-w, Lee, D-h, Lee, S-g, CRISPR interference-guided balancing of a biosynthetic mevalonate pathway increases terpenoid production. Metab Eng 38 (2016), 228–240.
118. Lv, L., Ren, Y-l, Chen, J-c, Wu, Q., Chen, G-q, Application of CRISPRi for prokaryotic metabolic engineering involving multiple genes, a case study : Controllable P (3HB- co -4HB) biosynthesis. Metab Eng 29 (2015), 160–168.
119. Gao, C., Wang, S., Hu, G., Guo, L., Chen, X., Engineering Escherichia coli for malate production by integrating modular pathway characterization with CRISPRi-guided multiplexed metabolic tuning. Biotechnol Bioeng 115 (2017), 661–672.
120. Kim, S.K., Seong, W., Han, G.H., Lee, D.H., Lee, S.G., CRISPR interference - guided multiplex repression of endogenous competing pathway genes for redirecting metabolic flux in Escherichia coli. Microb Cell Fact, 2017, 1–15.
121. Chu, L.L., Dhakal, D., Shin, H.J., Jung, H.J., Yamaguchi, T., Sohng, J.K., Metabolic engineering of Escherichia coli for enhanced production of naringenin 7-sulfate and its biological activities. Front Microbiol, 9, 2018, 1671.
122. Wu, H., Li, Y., Ma, Q., Li, Q., Jia, Z., Yang, B., Xu, Q., Fan, X., Zhang, C., Chen, N., et al. Metabolic engineering of Escherichia coli for high-yield uridine production. Metab Eng 49 (2018), 248–256.
123. Zhao, M., Huang, D., Zhang, X., Koffas, M.A.G., Zhou, J., Deng, Y., Metabolic engineering of Escherichia coli for producing adipic acid through the reverse adipate-degradation pathway. Metab Eng 47 (2018), 254–262.
124. Wu, J., Du, G., Chen, J., Zhou, J., Enhancing flavonoid production by systematically tuning the central metabolic pathways based on a CRISPR interference system in Escherichia coli. Sci Rep, 5, 2015, 13477.
125. Li, S., Bille, C., Grünberger, A., Ronda, C., Ingemann, S., Noack, S., Toftgaard, A., Novo, T., Foundation, N., Lyngby, K., Enhanced protein and biochemical production using CRISPRi-based growth switches. Metab Eng 38 (2016), 274–284.
126. Nielsen, A.A.K., Voigt, C.A., Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks. Mol Syst Biol, 10, 2014, 763.
127. Fontana, J., Voje, W.E., Zalatan, J.G., Carothers, J.M., Prospects for engineering dynamic CRISPR – Cas transcriptional circuits to improve bioproduction. J Ind Microbiol Biotechnol 45 (2018), 481–490.
128. Arazoe, T., Kondo, A., Nishida, K., Targeted Nucleotide Editing Technologies for Microbial Metabolic Engineering. Biotechnol J, 13, 2018, e1700596.
129. Banno, S., Nishida, K., Arazoe, T., Mitsunobu, H., Kondo, A., Deaminase-mediated multiplex genome editing in Escherichia coli. Nat Microbiol 3 (2018), 423–429.
130. Huang, H.H., Camsund, D., Lindblad, P., Heidorn, T., Design and characterization of molecular tools for a Synthetic Biology approach towards developing cyanobacterial biotechnology. Nucleic Acids Res 38 (2010), 2577–2593.
131. Armshaw, P., Carey, D., Sheahan, C., Pembroke, J.T., Utilising the native plasmid, pCA2.4, from the cyanobacterium Synechocystis sp. strain PCC6803 as a cloning site for enhanced product production. Biotechnol Biofuels, 8, 2015, 201.
132. Ng, A.H., Berla, B.M., Pakrasi, H.B., Fine-tuning of photoautotrophic protein production by combining promoters and neutral sites in the cyanobacterium Synechocystis sp. strain PCC 6803. Appl Environ Microbiol 81 (2015), 6857–6863.
133. Ramey, C.J., Baron-Sola, A., Aucoin, H.R., Boyle, N.R., Genome engineering in cyanobacteria: where we are and where we need to go. ACS Synth Biol 4 (2015), 1186–1196.
134. Ungerer, J., Pakrasi, H.B., Cpf1 is a versatile tool for CRISPR genome editing across diverse species of cyanobacteria. Sci Rep, 6, 2016, 39681.
135. Matson, M.M., Atsumi, S., Photomixotrophic chemical production in cyanobacteria. Curr Opin Biotechnol 50 (2017), 65–71.
136. Zhang, A., Carroll, A.L., Atsumi, S., Carbon recycling by cyanobacteria: improving CO2 fixation through chemical production. FEMS Microbiol Lett, 2017, 364.
137. Carroll, A.L., Case, A.E., Zhang, A., Atsumi, S., Metabolic engineering tools in model cyanobacteria. Metab Eng, 2018 pii: S1096-7176(18)30038-7.
138. Gao, F., Zhao, J., Chen, L., Battchikova, N., Ran, Z., Aro, E.M., Ogawa, T., Ma, W., The NDH-1L-PSI supercomplex is important for efficient cyclic electron transport in cyanobacteria. Plant Physiol 172 (2016), 1451–1464.
139. Wang, Y., Gao, Y., Li, C., Gao, H., Zhang, C.C., Xu, X., Three substrains of the cyanobacterium Anabaena sp. strain PCC 7120 display divergence in genomic sequences and hetC function. J Bacteriol, 200, 2018.
140. Luan, G., Lu, X., Tailoring cyanobacterial cell factory for improved industrial properties. Biotechnol Adv 36 (2018), 430–442.
141. Xie, M., Wang, W., Zhang, W., Chen, L., Lu, X., Versatility of hydrocarbon production in cyanobacteria. Appl Microbiol Biotechnol 101 (2017), 905–919.
142. Huang, X., Liang, Y., Yang, Y., Lu, X., Single-step production of the simvastatin precursor monacolin J by engineering of an industrial strain of Aspergillus terreus. Metab Eng 42 (2017), 109–114.
143. Taton, A., Unglaub, F., Wright, N.E., Zeng, W.Y., Paz-Yepes, J., Brahamsha, B., Palenik, B., Peterson, T.C., Haerizadeh, F., Golden, S.S., et al. Broad-host-range vector system for synthetic biology and biotechnology in cyanobacteria. Nucleic Acids Res, 42, 2014, e136.
144. Song, X., Wang, Y., Diao, J., Li, S., Chen, L., Zhang, W., Direct photosynthetic production of plastic building block chemicals from CO2. Adv Exp Med Biol 1080 (2018), 215–238.
145. Li, S., Sun, T., Xu, C., Chen, L., Zhang, W., Development and optimization of genetic toolboxes for a fast-growing cyanobacterium Synechococcus elongatus UTEX 2973. Metab Eng 48 (2018), 163–174.
146. Zhou, J., Meng, H., Zhang, W., Li, Y., Production of industrial chemicals from CO2 by engineering cyanobacteria. Adv Exp Med Biol 1080 (2018), 97–116.
147. Zhou, J., Zhang, F., Meng, H., Zhang, Y., Li, Y., Introducing extra NADPH consumption ability significantly increases the photosynthetic efficiency and biomass production of cyanobacteria. Metab Eng 38 (2016), 217–227.
148. Zhou, J., Zhu, T., Cai, Z., Li, Y., From cyanochemicals to cyanofactories: a review and perspective. Microb Cell Fact, 15, 2016, 2.
149. Ni, J., Tao, F., Xu, P., Yang, C., Engineering cyanobacteria for photosynthetic production of C3 platform chemicals and terpenoids from CO2. Adv Exp Med Biol 1080 (2018), 239–259.
150. Wendt, K.E., Ungerer, J., Cobb, R.E., Zhao, H., Pakrasi, H.B., CRISPR/Cas9 mediated targeted mutagenesis of the fast growing cyanobacterium Synechococcus elongatus UTEX 2973. Microb Cell Fact, 15, 2016, 115.
151. Xiao, Y., Wang, S., Rommelfanger, S., Balassy, A., Barba-Ostria, C., Gu, P., Galazka, J.M., Zhang, F., Developing a Cas9-based tool to engineer native plasmids in Synechocystis sp. PCC 6803. Biotechnol Bioeng 115 (2018), 2305–2314.
152. Griese, M., Lange, C., Soppa, J., Ploidy in cyanobacteria. FEMS Microbiol Lett 323 (2011), 124–131.
153. Li, H., Shen, C.R., Huang, C.H., Sung, L.Y., Wu, M.Y., Hu, Y.C., CRISPR-Cas9 for the genome engineering of cyanobacteria and succinate production. Metab Eng 38 (2016), 293–302.
154. Robertsen, H.L., Weber, T., Kim, H.U., Lee, S.Y., Toward systems metabolic engineering of streptomycetes for secondary metabolites production. Biotechnol J, 13, 2018.
155. Xu, D.B., Ye, W.W., Han, Y., Deng, Z.X., Hong, K., Natural products from mangrove actinomycetes. Mar Drugs 12 (2014), 2590–2613.
156. Lv, M., Ji, X., Zhao, J., Li, Y., Zhang, C., Su, L., Ding, W., Deng, Z., Yu, Y., Zhang, Q., Characterization of a C3 deoxygenation pathway reveals a key branch point in aminoglycoside biosynthesis. J Am Chem Soc 138 (2016), 6427–6435.
157. Tan, G.Y., Deng, K., Liu, X., Tao, H., Chang, Y., Chen, J., Chen, K., Sheng, Z., Deng, Z., Liu, T., Heterologous biosynthesis of spinosad: an omics-guided large polyketide synthase gene cluster reconstitution in Streptomyces. ACS Synth Biol 6 (2017), 995–1005.
158. Tan, G.Y., Liu, T., Rational synthetic pathway refactoring of natural products biosynthesis in actinobacteria. Metab Eng 39 (2017), 228–236.
159. Song, L.Q., Zhang, Y.Y., Pu, J.Y., Tang, M.C., Peng, C., Tang, G.L., Catalysis of extracellular deamination by a FAD-linked oxidoreductase after prodrug maturation in the biosynthesis of saframycin A. Angew Chem Int Ed Engl 56 (2017), 9116–9120.
160. Lin, Z., He, Q., Liu, W., Bio-inspired engineering of thiopeptide antibiotics advances the expansion of molecular diversity and utility. Curr Opin Biotechnol 48 (2017), 210–219.
161. Gao, Q., Tan, G.Y., Xia, X., Zhang, L., Learn from microbial intelligence for avermectins overproduction. Curr Opin Biotechnol 48 (2017), 251–257.
162. Gui, C., Liu, Y., Zhou, Z., Zhang, S., Hu, Y., Gu, Y.C., Huang, H., Ju, J., Angucycline glycosides from mangrove-derived streptomycesdiastaticus subsp. SCSIO GJ056. Mar Drugs, 2018, 16.
163. Pokhrel, A.R., Nguyen, H.T., Dhakal, D., Chaudhary, A.K., Sohng, J.K., Implication of orphan histidine kinase (OhkAsp) in biosynthesis of doxorubicin and daunorubicin in Streptomyces peucetius ATCC 27952. Microbiol Res 214 (2018), 37–46.
164. Hahn, D.R., Graupner, P.R., Chapin, E., Gray, J., Heim, D., Gilbert, J.R., Gerwick, B.C., Albucidin: a novel bleaching herbicide from Streptomyces albus subsp. chlorinus NRRL B-24108. J Antibiot (Tokyo) 62 (2009), 191–194.
165. Kim, M., Sang Yi, J., Kim, J., Kim, J.N., Kim, M.W., Kim, B.G., Reconstruction of a high-quality metabolic model enables the identification of gene overexpression targets for enhanced antibiotic production in Streptomyces coelicolor A3(2). Biotechnol J 9 (2014), 1185–1194.
166. Andexer, J.N., Kendrew, S.G., Nur-e-Alam, M., Lazos, O., Foster, T.A., Zimmermann, A.S., Warneck, T.D., Suthar, D., Coates, N.J., Koehn, F.E., et al. Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate. Proc Natl Acad Sci U S A 108 (2011), 4776–4781.
167. Baltz, R.H., Gifted microbes for genome mining and natural product discovery. J Ind Microbiol Biotechnol 44 (2017), 573–588.
168. Saha, S., Zhang, W., Zhang, G., Zhu, Y., Chen, Y., Liu, W., Yuan, C., Zhang, Q., Zhang, H., Zhang, L., et al. Activation and characterization of a cryptic gene cluster reveals a cyclization cascade for polycyclic tetramate macrolactams. Chem Sci 8 (2017), 1607–1612.
169. Yan, Y., Liu, Q., Zang, X., Yuan, S., Bat-Erdene, U., Nguyen, C., Gan, J., Zhou, J., Jacobsen, S.E., Tang, Y., Resistance-gene-directed discovery of a natural-product herbicide with a new mode of action. Nature 559 (2018), 415–418.
170. Doroghazi, J.R., Albright, J.C., Goering, A.W., Ju, K.S., Haines, R.R., Tchalukov, K.A., Labeda, D.P., Kelleher, N.L., Metcalf, W.W., A roadmap for natural product discovery based on large-scale genomics and metabolomics. Nat Chem Biol 10 (2014), 963–968.
171. Huang, H., Zheng, G., Jiang, W., Hu, H., Lu, Y., One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces. Acta Biochim Biophys Sin (Shanghai) 47 (2015), 231–243.
172. Cobb, R.E., Wang, Y., Zhao, H., High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system. ACS Synth Biol 4 (2015), 723–728.
173. Zeng, H., Wen, S., Xu, W., He, Z., Zhai, G., Liu, Y., Deng, Z., Sun, Y., Highly efficient editing of the actinorhodin polyketide chain length factor gene in Streptomyces coelicolor M145 using CRISPR/Cas9-CodA(sm) combined system. Appl Microbiol Biotechnol 99 (2015), 10575–10585.
174. Li, L., Wei, K., Zheng, G., Liu, X., Chen, S., Jiang, W., Lu, Y., CRISPR-Cpf1 assisted multiplex genome editing and transcriptional repression in Streptomyces. Appl Environ Microbiol, 2018 pii: e00827-18.
175. Jia, H., Zhang, L., Wang, T., Han, J., Tang, H., Development of a CRISPR/Cas9-mediated gene-editing tool in Streptomyces rimosus. Microbiology 163 (2017), 1148–1155.
176. Tong, Y., Charusanti, P., Zhang, L., Weber, T., Lee, S.Y., CRISPR-Cas9 based engineering of actinomycetal genomes. ACS Synth Biol 4 (2015), 1020–1029.
177. Zhang, M.M., Wong, F.T., Wang, Y., Luo, S., Lim, Y.H., Heng, E., Yeo, W.L., Cobb, R.E., Enghiad, B., Ang, E.L., et al. CRISPR-Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters. Nat Chem Biol 13 (2017), 607–611.
178. Bao, Z., Xiao, H., Liang, J., Zhang, L., Xiong, X., Sun, N., Si, T., Zhao, H., Homology-integrated CRISPR-Cas (HI-CRISPR) system for one-step multigene disruption in Saccharomyces cerevisiae. ACS Synth Biol 4 (2015), 585–594.
179. Kandler, O., Carbohydrate metabolism in lactic acid bacteria. Antonie Leeuwenhoek 49 (1983), 209–224.
180. Sauer, M., Russmayer, H., Grabherr, R., Peterbauer, C.K., Marx, H., The efficient clade: lactic acid bacteria for industrial chemical production. Trends Biotechnol 35 (2017), 756–769.
181. Vlasova, A.N., Kandasamy, S., Chattha, K.S., Rajashekara, G., Saif, L.J., Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species. Vet Immunol Immunopathol 172 (2016), 72–84.
182. Lindlbauer, K.A., Marx, H., Sauer, M., Effect of carbon pulsing on the redox household of Lactobacillus diolivorans in order to enhance 1,3-propanediol production. N Biotechnol 34 (2017), 32–39.
183. Liu, F., Yu, B., Efficient production of reuterin from glycerol by magnetically immobilized Lactobacillus reuteri. Appl Microbiol Biotechnol 99 (2015), 4659–4666.
184. Dishisha, T., Pyo, S.H., Hatti-Kaul, R., Bio-based 3-hydroxypropionic- and acrylic acid production from biodiesel glycerol via integrated microbial and chemical catalysis. Microb Cell Fact, 14, 2015, 200.
185. Yang, Y., Kang, Z., Zhou, J., Chen, J., Du, G., High-level expression and characterization of recombinant acid urease for enzymatic degradation of urea in rice wine. Appl Microbiol Biotechnol 99 (2015), 301–308.
186. Song, X., Huang, H., Xiong, Z., Ai, L., Yang, S., CRISPR-Cas9(D10A) nickase-assisted genome editing in Lactobacillus casei. Appl Environ Microbiol, 83, 2017.
187. Stout, E.A., Sanozky-Dawes, R., Goh, Y.J., Crawley, A.B., Klaenhammer, T.R., Barrangou, R., Deletion-based escape of CRISPR-Cas9 targeting in Lactobacillus gasseri. Microbiology 164 (2018), 1098–1111.
188. He, M., Miyajima, F., Roberts, P., Ellison, L., Pickard, D.J., Martin, M.J., Connor, T.R., Harris, S.R., Fairley, D., Bamford, K.B., et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45 (2013), 109–113.
189. Patakova, P., Kolek, J., Sedlar, K., Koscova, P., Branska, B., Kupkova, K., Paulova, L., Provaznik, I., Comparative analysis of high butanol tolerance and production in clostridia. Biotechnol Adv 36 (2018), 721–738.
190. Ren, C., Wen, Z., Xu, Y., Jiang, W., Gu, Y., Clostridia: a flexible microbial platform for the production of alcohols. Curr Opin Chem Biol 35 (2016), 65–72.
191. Joseph, R.C., Kim, N.M., Sandoval, N.R., Recent developments of the synthetic biology toolkit for Clostridium. Front Microbiol, 9, 2018, 154.
192. Xue, C., Zhao, J., Chen, L., Yang, S.T., Bai, F., Recent advances and state-of-the-art strategies in strain and process engineering for biobutanol production by Clostridium acetobutylicum. Biotechnol Adv 35 (2017), 310–322.
193. Wang, Y., Zhang, Z.T., Seo, S.O., Choi, K., Lu, T., Jin, Y.S., Blaschek, H.P., Markerless chromosomal gene deletion in Clostridium beijerinckii using CRISPR/Cas9 system. J Biotechnol 200 (2015), 1–5.
194. Wang, Y., Zhang, Z.T., Seo, S.O., Lynn, P., Lu, T., Jin, Y.S., Blaschek, H.P., Bacterial genome editing with CRISPR-Cas9: deletion, integration, single nucleotide modification, and desirable “clean” mutant selection in Clostridium beijerinckii as an example. ACS Synth Biol 5 (2016), 721–732.
195. Wang, S., Dong, S., Wang, P., Tao, Y., Wang, Y., Genome editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 system. Appl Environ Microbiol, 83, 2017.
196. Li, Q., Chen, J., Minton, N.P., Zhang, Y., Wen, Z., Liu, J., Yang, H., Zeng, Z., Ren, X., Yang, J., et al. CRISPR-based genome editing and expression control systems in Clostridium acetobutylicum and Clostridium beijerinckii. Biotechnol J 11 (2016), 961–972.
197. Nagaraju, S., Davies, N.K., Walker, D.J., Kopke, M., Simpson, S.D., Genome editing of Clostridium autoethanogenum using CRISPR/Cas9. Biotechnol Biofuels, 9, 2016, 219.
198. Huang, H., Chai, C., Li, N., Rowe, P., Minton, N.P., Yang, S., Jiang, W., Gu, Y., CRISPR/Cas9-Based efficient genome editing in Clostridium ljungdahlii, an autotrophic gas-fermenting bacterium. ACS Synth Biol 5 (2016), 1355–1361.
199. Zhang, J., Zong, W., Hong, W., Zhang, Z.T., Wang, Y., Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production. Metab Eng 47 (2018), 49–59.
200. Pyne, M.E., Bruder, M.R., Moo-Young, M., Chung, D.A., Chou, C.P., Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium. Sci Rep, 6, 2016, 25666.
201. Hong, W., Zhang, J., Cui, G., Wang, L., Wang, Y., Multiplexed CRISPR-Cpf1-mediated genome editing in Clostridium difficile toward the understanding of pathogenesis of C. difficile infection. ACS Synth Biol 7 (2018), 1588–1600.
202. Xu, T., Li, Y., Shi, Z., Hemme, C.L., Zhu, Y., Van Nostrand, J.D., He, Z., Zhou, J., Efficient genome editing in Clostridium cellulolyticum via CRISPR-Cas9 nickase. Appl Environ Microbiol 81 (2015), 4423–4431.
203. Xu, T., Li, Y., He, Z., Van Nostrand, J.D., Zhou, J., Cas9 nickase-assisted RNA repression enables stable and efficient manipulation of essential metabolic genes in Clostridium cellulolyticum. Front Microbiol, 8, 2017, 1744.
204. Bruder, M.R., Pyne, M.E., Moo-Young, M., Chung, D.A., Chou, C.P., Extending CRISPR-Cas9 technology from genome editing to transcriptional engineering in the genus Clostridium. Appl Environ Microbiol 82 (2016), 6109–6119.
205. Wang, Y., Zhang, Z.T., Seo, S.O., Lynn, P., Lu, T., Jin, Y.S., Blaschek, H.P., Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9. Biotechnol Bioeng 113 (2016), 2739–2743.
206. Wen, Z., Minton, N.P., Zhang, Y., Li, Q., Liu, J., Jiang, Y., Yang, S., Enhanced solvent production by metabolic engineering of a twin-clostridial consortium. Metab Eng 39 (2017), 38–48.
207. Baumgart, M., Unthan, S., Kloss, R., Radek, A., Polen, T., Tenhaef, N., Muller, M.F., Kuberl, A., Siebert, D., Bruhl, N., et al. Corynebacterium glutamicum chassis C1*: building and testing a novel platform host for synthetic biology and industrial biotechnology. ACS Synth Biol 7 (2018), 132–144.
208. Becker, J., Rohles, C.M., Wittmann, C., Metabolically engineered Corynebacterium glutamicum for bio-based production of chemicals, fuels, materials, and healthcare products. Metab Eng, 2018 pii: S1096-7176(18)30152-6.
209. Jiang, Y., Qian, F., Yang, J., Liu, Y., Dong, F., Xu, C., Sun, B., Chen, B., Xu, X., Li, Y., et al. CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum. Nat Commun, 8, 2017, 15179.
210. Liu, J., Wang, Y., Lu, Y., Zheng, P., Sun, J., Ma, Y., Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum. Microb Cell Fact, 16, 2017, 205.
211. Peng, F., Wang, X., Sun, Y., Dong, G., Yang, Y., Liu, X., Bai, Z., Efficient gene editing in Corynebacterium glutamicum using the CRISPR/Cas9 system. Microb Cell Fact, 16, 2017, 201.
212. Cho, J.S., Choi, K.R., Prabowo, C.P.S., Shin, J.H., Yang, D., Jang, J., Lee, S.Y., CRISPR/Cas9-coupled recombineering for metabolic engineering of Corynebacterium glutamicum. Metab Eng 42 (2017), 157–167.
213. Wang, B., Hu, Q., Zhang, Y., Shi, R., Chai, X., Liu, Z., Shang, X., Wen, T., A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum. Microb Cell Fact, 17, 2018, 63.
214. Wang, Y., Liu, Y., Liu, J., Guo, Y., Fan, L., Ni, X., Zheng, X., Wang, M., Zheng, P., Sun, J., et al. MACBETH: multiplex automated Corynebacterium glutamicum base editing method. Metab Eng 47 (2018), 200–210.
215. Cleto, S., Jensen, J.V., Wendisch, V.F., Lu, T.K., Corynebacterium glutamicum metabolic engineering with CRISPR interference (CRISPRi). ACS Synth Biol 5 (2016), 375–385.
216. Park, J., Shin, H., Lee, S.M., Um, Y., Woo, H.M., RNA-guided single/double gene repressions in Corynebacterium glutamicum using an efficient CRISPR interference and its application to industrial strain. Microb Cell Fact, 17, 2018, 4.
217. Yoon, J., Woo, H.M., CRISPR interference-mediated metabolic engineering of Corynebacterium glutamicum for homo-butyrate production. Biotechnol Bioeng 115 (2018), 2067–2074.
218. Gu, Y., Xu, X., Wu, Y., Niu, T., Liu, Y., Li, J., Du, G., Liu, L., Advances and prospects of Bacillus subtilis cellular factories: from rational design to industrial applications. Metab Eng, 2018 pii: S1096-7176(17)30482-2.
219. Westbrook, A.W., Moo-Young, M., Chou, C.P., Development of a CRISPR-Cas9 tool kit for Comprehensive engineering of Bacillus subtilis. Appl Environ Microbiol 82 (2016), 4876–4895.
220. Westbrook, A.W., Ren, X., Moo-Young, M., Chou, C.P., Metabolic engineering of Bacillus subtilis for L-valine overproduction. Biotechnol Bioeng, 2018, 10.1002/bit.26789.
221. Westbrook, A.W., Ren, X., Oh, J., Moo-Young, M., Chou, C.P., Metabolic engineering to enhance heterologous production of hyaluronic acid in Bacillus subtilis. Metab Eng 47 (2018), 401–413.
222. Wu, Y., Chen, T., Liu, Y., Lv, X., Li, J., Du, G., Ledesma-Amaro, R., Liu, L., CRISPRi allows optimal temporal control of N-acetylglucosamine bioproduction by a dynamic coordination of glucose and xylose metabolism in Bacillus subtilis. Metab Eng 49 (2018), 232–241.
223. Zhang, K., Duan, X., Wu, J., Multigene disruption in undomesticated Bacillus subtilis ATCC 6051a using the CRISPR/Cas9 system. Sci Rep, 6, 2016, 27943.
224. Zhang, K., Su, L., Wu, J., Enhanced extracellular pullulanase production in Bacillus subtilis using protease-deficient strains and optimal feeding. Appl Microbiol Biotechnol 102 (2018), 5089–5103.
225. Mougiakos, I., Bosma, E.F., Weenink, K., Vossen, E., Goijvaerts, K., van der Oost, J., van Kranenburg, R., Efficient genome editing of a facultative thermophile using mesophilic spCas9. ACS Synth Biol 6 (2017), 849–861.
226. Mougiakos, I., Mohanraju, P., Bosma, E.F., Vrouwe, V., Finger Bou, M., Naduthodi, M.I.S., Gussak, A., Brinkman, R.B.L., van Kranenburg, R., van der Oost, J., Characterizing a thermostable Cas9 for bacterial genome editing and silencing. Nat Commun, 8, 2017, 1647.
227. Li, K., Cai, D., Wang, Z., He, Z., Chen, S., Development of an efficient genome editing tool in Bacillus licheniformis using CRISPR-Cas9 nickase. Appl Environ Microbiol, 84, 2018.
228. Petchiappan, A., Chatterji, D., Antibiotic resistance: current perspectives. ACS Omega 2 (2017), 7400–7409.
229. Gu, T., Zhao, S., Pi, Y., Chen, W., Chen, C., Liu, Q., Li, M., Han, D., Ji, Q., Highly efficient base editing in Staphylococcus aureus using an engineered CRISPR RNA-guided cytidine deaminase. Chem Sci 9 (2018), 3248–3253.
230. Chen, W., Zhang, Y., Yeo, W.S., Bae, T., Ji, Q., Rapid and efficient genome editing in Staphylococcus aureus by using an engineered CRISPR/Cas9 system. J Am Chem Soc 139 (2017), 3790–3795.
231. Dong, X., Jin, Y., Ming, D., Li, B., Dong, H., Wang, L., Wang, T., Wang, D., CRISPR/dCas9-mediated inhibition of gene expression in Staphylococcus aureus. J Microbiol Methods 139 (2017), 79–86.
232. Choudhary, E., Thakur, P., Pareek, M., Agarwal, N., Gene silencing by CRISPR interference in mycobacteria. Nat Commun, 6, 2015, 6267.
233. Rock, J.M., Hopkins, F.F., Chavez, A., Diallo, M., Chase, M.R., Gerrick, E.R., Pritchard, J.R., Church, G.M., Rubin, E.J., Sassetti, C.M., et al. Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat Microbiol, 2, 2017, 16274.
234. Singh, A.K., Carette, X., Potluri, L.P., Sharp, J.D., Xu, R., Prisic, S., Husson, R.N., Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system. Nucleic Acids Res, 44, 2016, e143.
235. Sun, B., Yang, J., Yang, S., Ye, R.D., Chen, D., Jiang, Y., A CRISPR-Cpf1-Assisted Non-Homologous End Joining Genome Editing System of Mycobacterium smegmatis. Biotechnol J, 2018, e1700588.
236. Gao, Y.Z., Liu, H., Chao, H.J., Zhou, N.Y., Constitutive expression of a nag-like dioxygenase gene through an internal promoter in the 2-Chloronitrobenzene Catabolism gene cluster of Pseudomonas stutzeri ZWLR2-1. Appl Environ Microbiol 82 (2016), 3461–3470.
237. Yu, H., Hausinger, R.P., Tang, H.Z., Xu, P., Mechanism of the 6-hydroxy-3-succinoyl-pyridine 3-monooxygenase flavoprotein from Pseudomonas putida S16. J Biol Chem 289 (2014), 29158–29170.
238. Aparicio, T., de Lorenzo, V., Martinez-Garcia, E., CRISPR/Cas9-Based Counterselection Boosts Recombineering Efficiency in Pseudomonas putida. Biotechnol J, 13, 2018, e1700161.
239. Sun, J., Wang, Q., Jiang, Y., Wen, Z., Yang, L., Wu, J., Yang, S., Genome editing and transcriptional repression in Pseudomonas putida KT2440 via the type II CRISPR system. Microb Cell Fact, 17, 2018, 41.
240. Tan, S.Z., Reisch, C.R., Prather, K.L.J., A robust CRISPR interference gene repression system in Pseudomonas. J Bacteriol, 200, 2018.
241. Shen, J., Zhou, J., Chen, G.Q., Xiu, Z.L., Efficient genome engineering of a virulent Klebsiella bacteriophage using CRISPR-Cas9. J Virol, 92, 2018.
242. Wang, J., Zhao, P., Li, Y., Xu, L., Tian, P., Engineering CRISPR interference system in Klebsiella pneumoniae for attenuating lactic acid synthesis. Microb Cell Fact, 17, 2018, 56.
243. Yan, M.Y., Yan, H.Q., Ren, G.X., Zhao, J.P., Guo, X.P., Sun, Y.C., CRISPR-Cas12a-Assisted recombineering in bacteria. Appl Environ Microbiol, 83, 2017.
244. Wang, Y.H., Wei, K.Y., Smolke, C.D., Synthetic biology: advancing the design of diverse genetic systems. Annu Rev Chem Biomol Eng 4 (2012), 69–102.
245. Gronenberg, L.S., Marcheschi, R.J., Liao, J.C., Next generation biofuel engineering in prokaryotes. Curr Opin Chem Biol 17 (2013), 462–471.
246. Woolston, B.M., Edgar, S., Stephanopoulos, G., Metabolic engineering: past and future. Annu Rev Chem Biomol Eng 4 (2013), 259–288.
247. Shao, J., Wang, M., Yu, G., Zhu, S., Yu, Y., Heng, B.C., Wu, J., Ye, H., Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation. Proc Natl Acad Sci U S A 115 (2018), E6722–E6730.
248. Sontheimer, E.J., Davidson, A.R., Inhibition of CRISPR-Cas systems by mobile genetic elements. Curr Opin Microbiol 37 (2017), 120–127.
249. Cui, Y., Xu, J., Cheng, M., Liao, X., Peng, S., Review of CRISPR/Cas9 sgRNA design tools. Interdiscip Sci 10 (2018), 455–465.
250. Wong, N., Liu, W., Wang, X., Wu-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system. Genome Biol, 16, 2015, 218.
251. Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O., et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31 (2013), 827–832.
252. Perez, A.R., Pritykin, Y., Vidigal, J.A., Chhangawala, S., Zamparo, L., Leslie, C.S., Ventura, A., GuideScan software for improved single and paired CRISPR guide RNA design. Nat Biotechnol 35 (2017), 347–349.
253. Stemmer, M., Thumberger, T., Del Sol Keyer, M., Wittbrodt, J., Mateo, J.L., CCTop: an Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool. PloS One, 10, 2015, e0124633.
254. Chari, R., Yeo, N.C., Chavez, A., Church, G.M., sgRNA scorer 2.0: a species-independent model to predict CRISPR/Cas9 activity. ACS Synth Biol 6 (2017), 902–904.
255. Montague, T.G., Cruz, J.M., Gagnon, J.A., Church, G.M., Valen, E., CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res 42 (2014), W401–W407.
256. Moreno-Mateos, M.A., Vejnar, C.E., Beaudoin, J.D., Fernandez, J.P., Mis, E.K., Khokha, M.K., Giraldez, A.J., CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat Methods 12 (2015), 982–988.
257. Heigwer, F., Zhan, T., Breinig, M., Winter, J., Brugemann, D., Leible, S., Boutros, M., CRISPR library designer (CLD): software for multispecies design of single guide RNA libraries. Genome Biol, 17, 2016, 55.
258. Heigwer, F., Kerr, G., Boutros, M., E-CRISP: fast CRISPR target site identification. Nat Methods 11 (2014), 122–123.
259. Ihry, R.J., Worringer, K.A., Salick, M.R., Frias, E., Ho, D., Theriault, K., Kommineni, S., Chen, J., Sondey, M., Ye, C., et al. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med 24 (2018), 939–946.